- Home
- BLRX vs ZDAI Comparison
BLRX vs ZDAI Comparison
Compare BLRX & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- ZDAI
- Stock Information
- Founded
- BLRX 2003
- ZDAI 2022
- Country
- BLRX Israel
- ZDAI Hong Kong
- Employees
- BLRX N/A
- ZDAI N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- Sector
- BLRX Health Care
- ZDAI Consumer Discretionary
- Exchange
- BLRX Nasdaq
- ZDAI Nasdaq
- Market Cap
- BLRX 17.1M
- ZDAI 15.6M
- IPO Year
- BLRX 2011
- ZDAI 2024
- Fundamental
- Price
- BLRX N/A
- ZDAI N/A
- Analyst Decision
- BLRX Strong Buy
- ZDAI
- Analyst Count
- BLRX 2
- ZDAI 0
- Target Price
- BLRX $19.00
- ZDAI N/A
- AVG Volume (30 Days)
- BLRX 52.2K
- ZDAI 5.5M
- Earning Date
- BLRX 11-24-2025
- ZDAI 10-21-2025
- Dividend Yield
- BLRX N/A
- ZDAI N/A
- EPS Growth
- BLRX N/A
- ZDAI N/A
- EPS
- BLRX N/A
- ZDAI N/A
- Revenue
- BLRX $17,251,000.00
- ZDAI $19,275,673.00
- Revenue This Year
- BLRX N/A
- ZDAI N/A
- Revenue Next Year
- BLRX N/A
- ZDAI N/A
- P/E Ratio
- BLRX N/A
- ZDAI N/A
- Revenue Growth
- BLRX 1.19
- ZDAI 43.16
- 52 Week Low
- BLRX $2.30
- ZDAI $0.37
- 52 Week High
- BLRX $22.60
- ZDAI $107.36
- Technical
- Relative Strength Index (RSI)
- BLRX 69.50
- ZDAI 53.83
- Support Level
- BLRX $3.57
- ZDAI $0.62
- Resistance Level
- BLRX $4.56
- ZDAI $0.66
- Average True Range (ATR)
- BLRX 0.27
- ZDAI 0.05
- MACD
- BLRX 0.08
- ZDAI -0.00
- Stochastic Oscillator
- BLRX 87.13
- ZDAI 21.30
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About ZDAI Primega Group Holdings Limited Ordinary Shares
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.